Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies ; volume:15 ; number:1 ; day:12 ; month:6 ; year:2017 ; pages:1-10 ; date:12.2017
Health and quality of life outcomes ; 15, Heft 1 (12.6.2017), 1-10, 12.2017
- Keyword
-
Endokrinologie
- Creator
-
Suzuki, Shuichi
- Contributor
-
Oura, Tomonori
Takeuchi, Masakazu
Boye, Kristina S.
SpringerLink (Online service)
- DOI
-
10.1186/s12955-017-0696-7
- URN
-
urn:nbn:de:1111-20170906481
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suzuki, Shuichi
- Oura, Tomonori
- Takeuchi, Masakazu
- Boye, Kristina S.
- SpringerLink (Online service)
Other Objects (12)
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling
Inequality Comparisons with Ordinal Data
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling
Inequality Comparisons with Ordinal Data
Once More with Feeling
Once more, with Feeling
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Liraglutide restores impaired associative learning in individuals with obesity
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
Ida & Laura; Once more with feeling
VIII. With the B.E.F. once more
Learn Once - Write Anywhere with React
Ida & Laura : Once More With Feeling